Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.09

+0.59 (1.10%)

as of Jun 5, 2026, 3:10:33 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

HOLD

Massive investment in Asia is one of the positives. Long-term opportunity is good. Interest rate sensitivity of the lifecos can have a magnified effect the stock price. As a long-term investor, don't worry about this.

TOP PICK

Goes back to the caution on broader market. Has not seen a big run like other stocks. Yields over 4% at current levels and could increase it. Continued growth trends. Collect your dividend while you are in a stable entity and wait for upside. Good for when things look frothy. (Analysts’ price target is $29.02)

PAST TOP PICK

(A Top Pick Jun 05/20, Up 31%) They have had a great run. The company has underlying good things happening. Looking for better days.

HOLD

Likes it and a lot of the insurers. A good long-term name, though he owns SLF and GWO instead. Expects dividend to increase over time by 8-10% yearly. Pullback due to interest rates coming down. Rates will probably move higher 12-24 months out. Asia exposure is a growing segment. Yield is 4%.

HOLD

It is the most discounted insurance company in Canada. It is trading at this level because it has been the performance laggard for quite some time. It has become a show-me story. However if you were going to buy an insurance company, this would be the one to buy. There is the chance of a bounce back or a trading opportunity. It has a decent dividend while you wait for an uptick.

BUY ON WEAKNESS

Would hold and it is getting close to adding back to it. They are one of the biggest at risk plays of interest rates going down. They are geared to benefit from higher interest rates. Moves out of financials is hurting their stock price. Would add on weakness.

TOP PICK

Canada's largest lifeco. Geographically diversified. Asia is demographically advantaged. The US business is lagging, but they're working on this. Canadian business is steady-eddy. Investing relentlessly in tech. Stock is inexpensive. Yield is 4.44%. (Analysts’ price target is $28.83)

BUY

The most volatile of Canadian lifecos, because it has the greatest difference between reported earnings and core earnings due to having a ton of both market and interest rate exposure. Likes it. Nice franchise in the US and Asian exposure to the emerging consumer. It's done increasingly well the last 10 years.

BUY

Interesting, likes the name. Perhaps management doesn't pay out more to shareholders or buy back shares because they want to expand or keep cash on hand. Doing well. Will benefit long-term from growth in Asia. 7-8x forward earnings, with 7-9% earnings growth going forward. Revenues and earnings will grow. He owns SLF and GWO instead. Yield of 4.5%.

BUY

Banks or lifecos? She likes both sectors, so it's not an either-or question. Banks will benefit from the reopening/recovery. She expects earnings upside and revisions probably later this year. Bank stocks have had a nice rally this year, but long term they remain attractive given their yields. The lifecos' valuations remain good, and wealth management offers key growth. She likes MFC's presence in Asia for its strong long-term growth. She owns TD, Royal and BNS.

DON'T BUY

He does not own life insurance companies as they are the most commoditized form of insurance. The banks have done better than the insurance companies (11% vs. 5%) unless you are looking for a short term trade, he would favour a bank. (Analysts’ price target is $29.00)

BUY

MFC vs. SLF Equally good. Prefers MFC for the great Asian franchise, which has a lot of opportunity. Has also built a great asset management business that has continued to do well. MFC has a great growth profile at a cheaper multiple. MFC gets the nod, but you can own both. They're great businesses that will continue to pay a good dividend for many years.

BUY

He continues to try to look at the big picture. It is cheaper than SLF-T with potentially more horsepower in terms of growth and it has a higher dividend yield. The opportunity in MFC-T comes from management. Changes they make do not come overnight. The recent drop is a buying opportunity.

DON'T BUY

The reason it went down after the blowout earnings is related to the financial crisis. During the crisis, MFC almost went out of business. They totally de-risked themselves coming out of the crisis. They never benefitted from good times. The best thing for insurance companies is for interest rates go up. Prefers Sunlife, a much better company.

TOP PICK

Expecting good numbers from all the lifecos. Extremely well capitalized. Asian operations doing extremely well. Should see dividend increases and capital appreciation. Inexpensive relative to peers. Yield is 4.26%. (Analysts’ price target is $28.10)

Showing 241 to 255 of 2,279 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)